论文部分内容阅读
哮喘急性发作期患儿47例。男28例,女19例。年龄4～12岁,其中学龄前组23例,学龄组24例。均给予抗过敏(扑尔敏、苯噻啶、酮替芬)及茶硷类药物,学龄前组每次各1/2～3/4片,学龄组每次各1片,Q8h口服,2～3周后Q12h口服,共6周。急性发作初期,加服泼尼松1～2mg/kg·d,约3～5天。于治疗前,治疗1、3、6周后用英国产峰流仪测定患儿最大呼气流速(PEFR),以观察治疗前后变化,并判定疗效。结果提示:学龄前组PEFR治疗前平均值为167.8±31.8,治疗1周后180.5±31.5,3周
47 cases of acute asthma in children. 28 males and 19 females. Age 4 to 12 years old, of which 23 cases of pre-school age, school-age group of 24 cases. All were given anti-allergy (chlorpheniramine, phenylthiazidine, ketotifen) and theophylline drugs, preschool group each 1/2 ~ 3/4 tablets, the school-age group each one, Q8h oral, 2 Q12h orally for ~ 3 weeks after a total of 6 weeks. Early acute attack, plus clothing prednisone 1 ~ 2mg / kg · d, about 3 to 5 days. Before treatment, after 1, 3 and 6 weeks of treatment, the maximum expiratory flow rate (PEFR) in children was measured by British peak-flow instrument to observe the changes before and after treatment and determine the curative effect. The results suggest that pre-PEFR pre-treatment group averaged 167.8 ± 31.8, 180.5 ± 31.5 after 1 week, 3 weeks